# Eupraxia (EPRX) — Earnings

EPRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/eprx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.19 |
| EPS estimate | −$0.18 |
| EPS surprise | −7.96% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 4, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1581178/000119312525264619/d35661d6k.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 4, 2025 | −$0.18 | −$0.19 | -7.96% | — | — |
| Q2 2025 | Aug 13, 2025 | −$0.19 | −$0.24 | -29.91% | — | — |
| Q1 2025 | May 6, 2025 | −$0.17 | −$0.18 | -8.16% | — | — |
| Q3 2024 | Nov 7, 2024 | −$0.13 | −$0.12 | 4.74% | — | — |
| Q2 2024 | Aug 7, 2024 | −$0.17 | −$0.12 | 26.68% | — | — |

## Frequently Asked Questions

### When did Eupraxia (EPRX) last report earnings?

Eupraxia last reported on Nov 4, 2025, covering fiscal Q3 2025.

### Did EPRX beat earnings estimates?

No. Eupraxia reported EPS of −$0.19 for Q3 2025 against a −$0.18 estimate — a 7.96% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).